Medifirst Burn Spray
FDA Label NDC 47682-225

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Unifirst First Aid Corporation for the product Medifirst Burn (NDC 47682-225). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient, purpose, uses, warnings, do not use, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Burn Spray

Pain Relief

Drug Facts

Active Ingredient

Lidocaine HCl 2.0%

Purpose

Topical pain relief

Uses

Temporary pain relief associated with minor burns

Warnings

For external use only

Do Not Use

  • In large quantities, particularly over raw or blistered areas
  • near eyes, if this happens rinse thoroughly with water

Otc - Stop Use

Stop use and ask doctor if condition worsens or persists for more than 7 days or clears up and returns

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

Directions

  • spray an even layer of burn spray over cleaned affected area not more than 3-4 times daily
  • not to be used on children under 12 years of age

Inactive Ingredients

aloe vera, germaben II, propylene glycol, purified water

Questions Or Comments?

1-800-634-7680

Principal Display Panel - Bottle Label

MEDI-FIRST ®

Burn Spray

Pump Spray

Analgesic

  • Relieves pain in minor burns
  • Washable
  • 2 FL OZ (59.1ML)

    Principal Display Panel (Bottle Label)

    Principal Display Panel (Bottle Label)

* Please review the disclaimer below.